Forgot?
Drug Approval
United States Food and Drug Administration
Treatment Outcome
Inhibitory Concentration 50
Models, Chemical
Drug Administration Schedule
United States
Clinical Trials as Topic
Injections, Subcutaneous
Azacitidine
Antineoplastic Agents, Hormonal
Quinazolines
Triazoles
Antimetabolites, Antineoplastic
Nitriles
Receptor, Epidermal Growth Factor
Oestradiol
Myelodysplastic Syndromes
Non-Small Cell Lung Carcinoma
Postmenopause
Co-Publications
3
2
1
Flash Player Required